Study held to see effect of Nimba Amalaki tablet and Trunakadi oinment in management of Tinea.

A single arm clinical study to evaluate the efficacy of Nimba Amalaki Ghanavati and Trunakadi oinment in management of Dadru (Tinea).

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039508

Enrollment

Registered

2022-01-18

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical features of Dadru irrespective of chronicity.

Exclusion criteria

Exclusion criteria: 1)Chronic illness and infection like TB skin cancer psoriasis Hansen disease generalized eczema malignant condition 2)person who is taking modern medicine for dadru 3)patients associated with other type of kushtha 4)Lesions with secondary infection

Design outcomes

Primary

Measure	Time frame
To evaluate effect of Nimba Amalaki ghanavati and Trunakadi ointment on Dadru (tinea) To evaluate the reduction of elevated circular lesions by the application of Trunakadi ointment and administration of Nimba Amalaki ghanavati in management of dadruTimepoint: 14 days study with 2 follow ups (7th,14th day)	—

Secondary

Measure	Time frame
To evaluate the reduction of elevated circular lesions by the application of Trunakadi ointment and administration of Nimba Amalaki ghanavati in management of dadruTimepoint: 14 days study	—

Countries

India

Contacts

Public ContactMohini Bhagwan Niware

Dr. D.Y. Patil College of ayurved and research centre Pimpri Pune

drdgdipankar@gmail.com9822279321

Outcome results